Mereo BioPharma Group PLC ADR Capital Reinvestment Ratio

Latest as of June 2021: 0.02x

Mereo BioPharma Group PLC ADR capital reinvestment ratio. Mereo BioPharma Group PLC ADR (MREO) has a Capital Reinvestment Ratio of 0.02x as of June 2021, meaning it reinvests 0% of its operating cash flow ($13.75 Million) in capital expenditures ($267.50K). Check Mereo BioPharma Group PLC ADR total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

$13.75 Million

USD

Capital Expenditures

$267.50K

USD

Data as of

Jun 2021

Most recent filing

Mereo BioPharma Group PLC ADR Capital Reinvestment Ratio by Year (None–None)

Mereo BioPharma Group PLC ADR capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see how efficiently does Mereo BioPharma Group PLC ADR generate cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow